Saltar al contenido
Merck

Collagen cross-linking and corneal infections.

Current opinion in ophthalmology (2013-05-25)
Joanne B Tayapad, Aileen Q Viguilla, Johann M G Reyes
RESUMEN

This review presents current data regarding the use of collagen cross-linking in the management of corneal infections. Infectious keratitis can lead to blindness without proper antimicrobial therapy. The disease can still progress and lead to corneal melt despite early detection and management. The aggressive nature of corneal pathogens and the threat of antibiotic-resistance make it necessary to develop newer ways of managing this rapidly progressive condition. Collagen cross-linking is a noninvasive ocular surface procedure that is used to effectively strengthen the cornea. This technique presents as a novel treatment option to halt the progression of keratoconus and ectasia. More recently, however, several articles have demonstrated the effectiveness of cross-linking in treating infectious keratitis via direct microbiologic cure and possibly, inhibition of corneal enzymatic degradation by common pathogenic organisms. Current literature reveals that corneal collagen cross-linking holds promise in treating infectious keratitis. However, larger-scale, randomized, controlled trials comparing cross-linking to standard antibiotic therapy are still warranted to support these findings.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Colágeno from human placenta, Bornstein and Traub Type IV, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Colágeno, tipo I solution from rat tail, BioReagent, suitable for cell culture, sterile-filtered
Sigma-Aldrich
Colágeno from human placenta, Bornstein and Traub Type IV, powder
Sigma-Aldrich
Colágeno from rat tail, Bornstein and Traub Type I, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Collagen from calf skin, Bornstein and Traub Type I, solid, BioReagent, suitable for cell culture
Sigma-Aldrich
(−)-Riboflavina, from Eremothecium ashbyii, ≥98%
Sigma-Aldrich
Collagen from bovine achilles tendon, powder, suitable for substrate for collagenase
Sigma-Aldrich
(−)-Riboflavina, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
Sigma-Aldrich
Collagen Type IV from human cell culture, Bornstein and Traub Type IV, 0.3 mg/mL, sterile-filtered, BioReagent, suitable for cell culture
Supelco
Riboflavina (B2), analytical standard
Sigma-Aldrich
Collagen from calf skin, Bornstein and Traub Type I, (0.1% solution in 0.1 M acetic acid), aseptically processed, BioReagent, suitable for cell culture
Sigma-Aldrich
Collagen from chicken sternal cartilage, Type II (Miller), powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Colágeno from human placenta, Bornstein and Traub Type I (Sigma Type VIII), powder
Supelco
(−)-Riboflavina, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Collagen from bovine tracheal cartilage, Bornstein and Traub Type II, powder
Sigma-Aldrich
Collagen from Engelbreth-Holm-Swarm murine sarcoma basement membrane, Type IV (Miller), lyophilized powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Collagen human, Bornstein and Traub Type I, acid soluble, powder, ~95% (SDS-PAGE)
Sigma-Aldrich
(−)-Riboflavina, meets USP testing specifications
Sigma-Aldrich
Colágeno from human placenta, Bornstein and Traub Type III (Sigma Type X), powder
Sigma-Aldrich
Collagen from bovine nasal septum, Bornstein and Traub Type II, powder
Sigma-Aldrich
Colágeno from human placenta, Bornstein and Traub Type IV, solution, suitable for cell culture, High Performance
Sigma-Aldrich
Colágeno from human placenta, Bornstein and Traub Type V (Sigma Type IX), powder
Sigma-Aldrich
Colágeno from human placenta, Bornstein and Traub Type IV, powder
Sigma-Aldrich
Collagen from rabbit skin, Bornstein and Traub Type I, powder
(−)-Riboflavina, European Pharmacopoeia (EP) Reference Standard